Total Payments
$2,471
2023 Payments
$295.67
Companies
31
Transactions
113
Medicare Patients
5,379
Medicare Billing
$968,552
Payment Breakdown by Category
Food & Beverage$2,471 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,471 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $531.21 | 15 | $0 (2021) |
| Amgen Inc. | $371.29 | 15 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $192.94 | 17 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $109.26 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.53 | 4 | $0 (2023) |
| Novo Nordisk Inc | $86.06 | 4 | $0 (2021) |
| PFIZER INC. | $84.02 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $83.88 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $83.17 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $73.74 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $295.67 | 11 | GlaxoSmithKline, LLC. ($83.88) |
| 2021 | $102.80 | 5 | Novo Nordisk Inc ($24.95) |
| 2020 | $122.10 | 5 | Amgen Inc. ($32.05) |
| 2019 | $740.24 | 38 | Otsuka America Pharmaceutical, Inc. ($208.91) |
| 2018 | $508.76 | 24 | Amgen Inc. ($125.24) |
| 2017 | $700.95 | 30 | Otsuka America Pharmaceutical, Inc. ($213.23) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: Hyperparathyroidism | ||||||
| 11/13/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.26 | General |
| Category: NEPHROLOGY | ||||||
| 10/18/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Hyperparathyroidism | ||||||
| 10/11/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.55 | General |
| 10/02/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: NEPHROLOGY | ||||||
| 09/06/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Nephrology | ||||||
| 08/30/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: Hyperparathyroidism | ||||||
| 08/14/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEPHROLOGY | ||||||
| 08/07/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $34.99 | General |
| Category: Nephrology | ||||||
| 08/02/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Cardiovascular | ||||||
| 08/02/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: Hyperparathyroidism | ||||||
| 07/10/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: VACCINES | ||||||
| 07/03/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: NEPHROLOGY | ||||||
| 07/01/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Hyperparathyroidism | ||||||
| 06/21/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Bone Health | ||||||
| 06/19/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Nephrology | ||||||
| 05/24/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: VACCINES | ||||||
| 05/15/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Hyperparathyroidism | ||||||
| 05/02/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Hyperparathyroidism | ||||||
| 04/26/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: Hyperparathyroidism | ||||||
| 04/11/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $115.19 | General |
| Category: NEPHROLOGY | ||||||
| 04/10/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: Nephrology | ||||||
| 03/27/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: Hyperparathyroidism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 376 | 595 | $563,426 | $91,628 |
| 2022 | 17 | 1,178 | 1,889 | $1.5M | $257,230 |
| 2021 | 20 | 1,789 | 2,903 | $968,963 | $331,375 |
| 2020 | 20 | 2,036 | 3,151 | $430,630 | $288,319 |
Total Patients
5,379
Total Services
8,538
Medicare Billing
$968,552
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 32 | 120 | $200,160 | $35,166 | 17.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 234 | $144,846 | $21,649 | 14.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 97 | 124 | $107,136 | $16,207 | 15.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 27 | 45 | $62,460 | $11,320 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $22,155 | $3,242 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $17,622 | $2,639 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 17 | $7,463 | $1,262 | 16.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $1,584 | $142.56 | 9.0% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 37 | 232 | $394,168 | $71,093 | 18.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 366 | 642 | $399,324 | $62,920 | 15.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 186 | 241 | $210,393 | $35,394 | 16.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 39 | 93 | $131,223 | $23,729 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 83 | 83 | $88,312 | $14,992 | 17.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 87 | 87 | $55,765 | $12,572 | 22.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 43 | 43 | $34,830 | $7,698 | 22.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 113 | $37,629 | $6,804 | 18.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 101 | $44,541 | $6,477 | 14.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 48 | $14,931 | $3,260 | 21.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 31 | $14,849 | $2,675 | 18.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 22 | $13,882 | $2,394 | 17.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $9,180 | $2,258 | 24.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $9,660 | $1,702 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 51 | $4,996 | $1,694 | 33.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $2,596 | $1,104 | 42.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 40 | $2,800 | $464.43 | 16.6% |
About Dr. Earl Gordon, M.D
Dr. Earl Gordon, M.D is a Nephrology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053534925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Earl Gordon, M.D has received a total of $2,471 in payments from pharmaceutical and medical device companies, with $295.67 received in 2023. These payments were reported across 113 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,471).
As a Medicare-enrolled provider, Gordon has provided services to 5,379 Medicare beneficiaries, totaling 8,538 services with total Medicare billing of $968,552. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Santa Monica, CA
- Active Since 04/10/2007
- Last Updated 11/21/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053534925
Products in Payments
- JYNARQUE (Drug) $317.98
- SAMSCA (Drug) $213.23
- Rayaldee (Drug) $192.94
- Parsabiv (Biological) $164.89
- Prolia (Biological) $90.51
- BENLYSTA (Biological) $83.88
- TREMFYA (Drug) $83.17
- LOKELMA (Drug) $73.74
- Saxenda (Drug) $68.51
- Uloric (Drug) $68.02
- ACTHAR (Biological) $63.91
- KRYSTEXXA (Drug) $60.52
- JARDIANCE (Drug) $60.10
- XARELTO (Drug) $57.45
- JANUVIA (Drug) $54.64
- Auryxia (Drug) $47.18
- RETACRIT (Biological) $46.87
- Vascepa (Drug) $41.23
- Edarbi (Drug) $40.34
- ASMANEX (Drug) $37.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Santa Monica
Dr. Connie Rhee, M.d, M.D
Nephrology — Payments: $99,698
Nephrology $99,698
Reza Khorsan, M.d, M.D
Nephrology — Payments: $6,844
Nephrology $6,844
Nasimeh Yazdani, M.d, M.D
Nephrology — Payments: $3,461
Nephrology $3,461
Fawad Zafar-Khan, Md, MD
Nephrology — Payments: $2,129
Nephrology $2,129
Ying Hui Luu, M.d, M.D
Nephrology — Payments: $716.35
Nephrology $716.35
Mark Nachman, Md, MD
Nephrology — Payments: $165.28
Nephrology $165.28